Results for tag: "Thalassaemia Drug"

Thalassaemia is a genetic disorder that affects the production of haemoglobin, leading to anemia. Treatment of thalassaemia involves the use of hematological drugs, which are drugs that are used to treat diseases of the blood and bone marrow. These drugs can be used to treat thalassaemia by increasing the production of red blood cells, reducing the need for blood transfusions, and improving the quality of life of those affected. The thalassaemia drug market is a rapidly growing market, driven by the increasing prevalence of thalassaemia and the development of new drugs to treat the condition. The market is expected to grow at a steady rate in the coming years, as more drugs are developed and approved for use. Some of the major companies in the thalassaemia drug market include Novartis, GlaxoSmithKline, Pfizer, Sanofi, and Bayer. These companies are involved in the development and marketing of drugs for the treatment of thalassaemia. Show Less Read more